Anker Lundemose

Anker Lundemose is the founder of MISSION Therapeutics. MISSION Therapeutics has raised $114M in total funding. Latest round: Series A.

About Anker Lundemose

Dr. Anker Lundemose is the Chief Executive Officer of MISSION Therapeutics, a clinical-stage biotech that develops therapeutics to enhance mitophagy for treating diseases such as Parkinson's and Acute Kidney Injury. He was appointed CEO of MISSION Therapeutics, and also serves as a Non-Executive Director at IsomAb.

Anker Lundemose at a glance

More founders in Cambridge, UK (44)

Browse related founder lists (6)

Full founder directory · Investor directory · Company funding database · Fundraising library